Athrombocytopenic thrombotic microangiopathy: diagnosis not performed with the present criteria

  • Lorenzo Marovelli Servicio de Nefrología, Sanatorio La Trinidad Mitre, Buenos Aires
  • Ignacio Larzábal Servicio de Nefrología, Sanatorio La Trinidad Mitre, Buenos Aires
  • Eugenia Zopi Servicio de Nefrología, Sanatorio La Trinidad Mitre, Buenos Aires
  • César Agost Carreño Servicio de Nefrología, Sanatorio La Trinidad Mitre, Buenos Aires
  • Martín Winkel Winkel Clínica Médica, Hospital General de Agudos Dr. Juan A. Fernández, Buenos Aires
  • Diana Miserendino Anatomía Patológica, Hospital General de Agudos José María Ramos Mejía, Buenos Aires
Keywords: athrombocytopenic thrombotic microangiopathy, thrombocytopenia, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, acute renal failure

Abstract

The disease category of thrombotic microangiopathy (TM) encompass different entities such as thrombocvtopenic thrombotic purpura (TTP) and uremic hemolytic syndrome (UHS), both strongly related and whose diagnosis relies on the presence of non immune hemolytic anemia and trombocytopenia, findings that should urge the caring physician to start plasmapheresis promptly. We report the case of a 51 year old woman admitted with acute-subacute renal failure of unknown etiology whose renal biopsy finding was thrombotic microangiopathy, in absence of thrombocytopenia and haemolytic anemia. This inusual case and according to published literature can not be diagnosed on standard accepted criteria and others markers like ADAMTS-13 should be considered.

References

Keir L, Coward RJ. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol. 2011;26(4):523-33.

Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol. 2008;3:249-77.

Franchini M. Thrombotic microangiopathies: an update. Hematology. 2006;11(3):139-46.

George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354(18):1927-35.

De Serres SA1, Isenring P. Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria. Nephrol Dial Transplant. 2009;24(3):1048-50.

Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102(1):60-8.

Veyradier A, Obert B, Houllier A, Meyer D, Girma JP. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood. 2001;98(6):1765-72.

López-Gómez JM, Rivera F; Spanish Registry of Glomerulonephritis. Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis. Clin J Am Soc Nephrol. 2008;3(3):674-81.

Published
2017-11-01
How to Cite
1.
Marovelli L, Larzábal I, Zopi E, Agost Carreño C, Winkel MW, Miserendino D. Athrombocytopenic thrombotic microangiopathy: diagnosis not performed with the present criteria. Rev Nefrol Dial Traspl. [Internet]. 2017Nov.1 [cited 2024Dec.23];32(1):47-0. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/194
Section
Case Report